Artificial intelligence has moved past the demonstration phase in healthcare. The harder question is no longer whether hospitals, physician groups, payers, and technology vendors can find use cases. Many already have. The more urgent question is whether healthcare organizations can govern AI with the same seriousness applied to medication safety, revenue integrity, privacy compliance, and clinical quality.

The cybersecurity incident disclosed by CareCloud should not be read only as another breach involving a health technology vendor. Its larger significance is more operational. A single electronic health record environment was reportedly affected for roughly eight hours, while other environments and systems were described as unaffected.

The new RAPID coverage pathway from the Centers for Medicare and Medicaid Services and the U.S. Food and Drug Administration reflects a long-running frustration in medical technology policy: authorization and coverage are separate decisions, and patients often wait in the gap between the two.

The question raised by Cedars-Sinai about whether artificial intelligence will replace human scientists is too narrow. The more important issue is whether agentic AI will make traditional research governance obsolete before institutions are ready to replace it with something stronger.